Burning Rock Biotech (BNR) Revenue: 2020-2025
Historic Revenue for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to $18.7 million.
- Burning Rock Biotech's Revenue fell 4.46% to $18.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.2 million, marking a year-over-year decrease of 1.36%. This contributed to the annual value of $70.7 million for FY2024, which is 6.64% down from last year.
- Per Burning Rock Biotech's latest filing, its Revenue stood at $18.7 million for Q3 2025, which was down 10.68% from $21.0 million recorded in Q2 2025.
- Burning Rock Biotech's Revenue's 5-year high stood at $23.7 million during Q4 2021, with a 5-year trough of $15.1 million in Q4 2024.
- In the last 3 years, Burning Rock Biotech's Revenue had a median value of $18.6 million in 2023 and averaged $18.6 million.
- Per our database at Business Quant, Burning Rock Biotech's Revenue soared by 31.37% in 2022 and then dropped by 18.84% in 2024.
- Over the past 5 years, Burning Rock Biotech's Revenue (MRQ) stood at $23.7 million in 2021, then fell by 5.32% to $22.5 million in 2022, then fell by 17.12% to $18.6 million in 2023, then dropped by 18.84% to $15.1 million in 2024, then rose by 23.89% to $18.7 million in 2025.
- Its last three reported values are $18.7 million in Q3 2025, $21.0 million for Q2 2025, and $18.3 million during Q1 2025.